Leland Gershell
Stock Analyst at Oppenheimer
(3.99)
# 1,680
Out of 4,386 analysts
755
Total ratings
38.7%
Success rate
5.8%
Average return
Main Sectors:
Stocks Rated by Leland Gershell
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRBP Corbus Pharmaceuticals Holdings | Reiterated: Buy | $54 | $7.56 | +614.29% | 18 | Jun 2, 2026 | |
| SPRB Spruce Biosciences | Reiterated: Buy | $283 → $230 | $50.43 | +356.08% | 4 | May 27, 2026 | |
| TARA Protara Therapeutics | Reiterated: Buy | $25 → $28 | $4.16 | +573.08% | 21 | May 20, 2026 | |
| URGN UroGen Pharma | Reiterated: Buy | $40 | $26.85 | +48.98% | 46 | May 19, 2026 | |
| EQ Equillium | Reiterated: Buy | $7 | $2.94 | +138.10% | 2 | May 15, 2026 | |
| CALC CalciMedica | Reiterated: Buy | $10 | $1.06 | +843.40% | 16 | May 15, 2026 | |
| CLYM Climb Bio | Reiterated: Buy | $18 | $10.55 | +70.62% | 5 | May 15, 2026 | |
| CRNX Crinetics Pharmaceuticals | Maintained: Buy | $87 → $84 | $32.92 | +155.16% | 19 | May 11, 2026 | |
| CAPR Capricor Therapeutics | Maintained: Buy | $54 | $26.71 | +102.17% | 22 | May 8, 2026 | |
| TRVI Trevi Therapeutics | Reiterated: Buy | $24 | $13.33 | +80.05% | 17 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.64 | - | 7 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $31.27 | - | 34 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.28 | +681.25% | 2 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $3.38 | +314.20% | 6 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $15.78 | - | 34 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $1,014 | $891.32 | +13.76% | 16 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $4.37 | +357.67% | 3 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $162 → $277 | $237.00 | +16.88% | 2 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 → $21 | $3.68 | +470.65% | 2 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $3.40 | +635.29% | 44 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $246 → $262 | $210.45 | +24.50% | 36 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $29.46 | - | 7 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $54 | $31.11 | +73.58% | 8 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $1.01 | +9,800.99% | 4 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $6.18 | +191.26% | 11 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $86.40 | - | 6 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $98 | $56.77 | +72.63% | 38 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $2.10 | +90.48% | 3 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $13.10 | +167.18% | 28 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $80 | $29.00 | +175.86% | 1 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $490 | $303.05 | +61.69% | 42 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $1.95 | n/a | 20 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $34.19 | n/a | 10 | May 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $106 | $71.48 | n/a | 3 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $1.02 | n/a | 19 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $3.83 | n/a | 17 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $1.23 | n/a | 19 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.30 | n/a | 16 | Jul 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $5.45 | n/a | 6 | Oct 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 | $0.13 | n/a | 11 | May 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 → $200 | $0.000001 | n/a | 11 | Mar 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $0.0144 | n/a | 1 | Jun 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 | $0.3525 | n/a | 11 | Jun 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7 | $1.00 | n/a | 16 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $42 | $1.77 | n/a | 7 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.0111 | n/a | 4 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $13.93 | n/a | 13 | Dec 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.97 | n/a | 22 | Dec 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.7767 | n/a | 9 | Dec 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0082 | n/a | 15 | Sep 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $0.7488 | n/a | 3 | May 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.775 | n/a | 9 | May 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $6.35 | n/a | 9 | Apr 3, 2019 |
Corbus Pharmaceuticals Holdings
Jun 2, 2026
Reiterated: Buy
Price Target: $54
Current: $7.56
Upside: +614.29%
Spruce Biosciences
May 27, 2026
Reiterated: Buy
Price Target: $283 → $230
Current: $50.43
Upside: +356.08%
Protara Therapeutics
May 20, 2026
Reiterated: Buy
Price Target: $25 → $28
Current: $4.16
Upside: +573.08%
UroGen Pharma
May 19, 2026
Reiterated: Buy
Price Target: $40
Current: $26.85
Upside: +48.98%
Equillium
May 15, 2026
Reiterated: Buy
Price Target: $7
Current: $2.94
Upside: +138.10%
CalciMedica
May 15, 2026
Reiterated: Buy
Price Target: $10
Current: $1.06
Upside: +843.40%
Climb Bio
May 15, 2026
Reiterated: Buy
Price Target: $18
Current: $10.55
Upside: +70.62%
Crinetics Pharmaceuticals
May 11, 2026
Maintained: Buy
Price Target: $87 → $84
Current: $32.92
Upside: +155.16%
Capricor Therapeutics
May 8, 2026
Maintained: Buy
Price Target: $54
Current: $26.71
Upside: +102.17%
Trevi Therapeutics
May 8, 2026
Reiterated: Buy
Price Target: $24
Current: $13.33
Upside: +80.05%
May 8, 2026
Maintained: Hold
Price Target: n/a
Current: $1.64
Upside: -
May 7, 2026
Downgraded: Hold
Price Target: n/a
Current: $31.27
Upside: -
May 6, 2026
Reiterated: Buy
Price Target: $10
Current: $1.28
Upside: +681.25%
Apr 23, 2026
Reiterated: Buy
Price Target: $14
Current: $3.38
Upside: +314.20%
Apr 13, 2026
Rated: Hold
Price Target: n/a
Current: $15.78
Upside: -
Apr 2, 2026
Rated: Buy
Price Target: $1,014
Current: $891.32
Upside: +13.76%
Mar 31, 2026
Reiterated: Buy
Price Target: $20
Current: $4.37
Upside: +357.67%
Feb 27, 2026
Maintained: Buy
Price Target: $162 → $277
Current: $237.00
Upside: +16.88%
Feb 27, 2026
Maintained: Buy
Price Target: $35 → $21
Current: $3.68
Upside: +470.65%
Feb 12, 2026
Reiterated: Buy
Price Target: $25
Current: $3.40
Upside: +635.29%
Feb 12, 2026
Maintained: Buy
Price Target: $246 → $262
Current: $210.45
Upside: +24.50%
Feb 10, 2026
Rated: Hold
Price Target: n/a
Current: $29.46
Upside: -
Feb 9, 2026
Maintained: Buy
Price Target: $54
Current: $31.11
Upside: +73.58%
Nov 14, 2025
Maintained: Buy
Price Target: $100
Current: $1.01
Upside: +9,800.99%
Nov 7, 2025
Maintained: Buy
Price Target: $18
Current: $6.18
Upside: +191.26%
Nov 4, 2025
Downgraded: Hold
Price Target: n/a
Current: $86.40
Upside: -
Oct 28, 2025
Reiterated: Buy
Price Target: $98
Current: $56.77
Upside: +72.63%
Oct 14, 2025
Reiterated: Buy
Price Target: $4
Current: $2.10
Upside: +90.48%
Sep 29, 2025
Reiterated: Buy
Price Target: $35
Current: $13.10
Upside: +167.18%
Sep 3, 2025
Initiated Coverage: Buy
Price Target: $80
Current: $29.00
Upside: +175.86%
Aug 4, 2025
Upgraded: Buy
Price Target: $490
Current: $303.05
Upside: +61.69%
Sep 16, 2024
Maintained: Buy
Price Target: $25
Current: $1.95
Upside: n/a
May 20, 2024
Rated: Hold
Price Target: n/a
Current: $34.19
Upside: n/a
May 14, 2024
Maintained: Buy
Price Target: $106
Current: $71.48
Upside: n/a
Mar 28, 2024
Initiated Coverage: Buy
Price Target: n/a
Current: $1.02
Upside: n/a
Dec 18, 2023
Maintained: Buy
Price Target: n/a
Current: $3.83
Upside: n/a
Nov 13, 2023
Maintained: Buy
Price Target: $11
Current: $1.23
Upside: n/a
Jul 10, 2023
Maintained: Buy
Price Target: n/a
Current: $2.30
Upside: n/a
Oct 4, 2022
Downgraded: Hold
Price Target: n/a
Current: $5.45
Upside: n/a
May 26, 2022
Maintained: Buy
Price Target: $60
Current: $0.13
Upside: n/a
Mar 21, 2022
Maintained: Buy
Price Target: $70 → $200
Current: $0.000001
Upside: n/a
Jun 4, 2021
Initiated Coverage: Buy
Price Target: $8
Current: $0.0144
Upside: n/a
Jun 2, 2021
Rated: Buy
Price Target: $12
Current: $0.3525
Upside: n/a
May 18, 2021
Rated: Buy
Price Target: $7
Current: $1.00
Upside: n/a
May 7, 2021
Initiated Coverage: Buy
Price Target: $42
Current: $1.77
Upside: n/a
May 6, 2021
Maintained: Hold
Price Target: n/a
Current: $0.0111
Upside: n/a
Dec 31, 2020
Rated: Hold
Price Target: n/a
Current: $13.93
Upside: n/a
Dec 31, 2020
Rated: Hold
Price Target: n/a
Current: $7.97
Upside: n/a
Dec 31, 2020
Rated: Hold
Price Target: n/a
Current: $0.7767
Upside: n/a
Sep 11, 2020
Rated: Hold
Price Target: n/a
Current: $0.0082
Upside: n/a
May 10, 2019
Reiterated: Buy
Price Target: $7
Current: $0.7488
Upside: n/a
May 9, 2019
Rated: Hold
Price Target: n/a
Current: $0.775
Upside: n/a
Apr 3, 2019
Reiterated: Buy
Price Target: $8
Current: $6.35
Upside: n/a